MIG Capital’s Edwards Lifesciences EW Stock Holding History

MIG Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,837	Closed	-$201K	–	26
2016 Q1	$201K	Buy	+6,837	New	+$189K	0.04%	26

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

MIG Capital's EW Position: Q2 2016 in Review

MIG Capital sold out of Edwards Lifesciences (EW) in Q2 2016, closing a stake of 6,837 shares — an estimated $201K sold.

MIG Capital first reported a position in EW in Q1 2016 and held it in 1 quarter. The position peaked at $201K in Q1 2016. 693 funds tracked by Wall St. Rank hold EW as of Q2 2016.

MIG Capital reported no remaining Edwards Lifesciences position as of Q2 2016 after selling out during the quarter.
MIG Capital sold 6,837 Edwards Lifesciences shares in Q2 2016, an estimated $201K.
MIG Capital first reported a position in Edwards Lifesciences in Q1 2016 and held it in 1 quarter.
MIG Capital's Edwards Lifesciences position peaked at $201K in Q1 2016.
693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on MIG Capital's 13F filing for Q2 2016, filed 15 Aug 2016.